RAAS inhibitors in COVID-19: They are not all the same!
Revista Portuguesa de Cardiologia · 2023
DOI: 10.1016/j.repc.2023.04.008 ↗Kurz gefasst
Leserbrief in der Zeitschrift Revista Portuguesa de Cardiologia, 2023. Verfasst von Chia Siang Kow und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. Electronic address: chiasiang_93@hotmail.com. Hauptthemen laut MEDLINE: COVID-19, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19.The COVID-19 resource centre is
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. Electronic address: chiasiang_93@hotmail.com.
- School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
- School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.
Zitieren
APA
Kow, C. S., Ramachandram, D. S., & Hasan, S. S. (2023). RAAS inhibitors in COVID-19: They are not all the same!. Revista Portuguesa de Cardiologia. https://doi.org/10.1016/j.repc.2023.04.008
Vancouver
Kow CS, Ramachandram DS, Hasan SS. RAAS inhibitors in COVID-19: They are not all the same!. Revista Portuguesa de Cardiologia. 2023. doi:10.1016/j.repc.2023.04.008
BibTeX
@article{Kow2023,
author = {Kow, Chia Siang and Ramachandram, Dinesh Sangarran and Hasan, Syed Shahzad},
title = {RAAS inhibitors in COVID-19: They are not all the same!},
journal = {Revista Portuguesa de Cardiologia},
year = {2023},
doi = {10.1016/j.repc.2023.04.008}
}
EUVIMED